학술논문
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies
Document Type
Article
Author
Source
In: Multiple Sclerosis . (Multiple Sclerosis, 1 September 2016, 22(10):1315-1326)
Subject
Language
English
ISSN
14770970
13524585
13524585